| Steven Palte, PA-C | |
|
801 Medical Dr, Suite A, Lima, OH 45804-4031 | |
| (419) 222-6622 | |
| (419) 224-0015 |
| Full Name | Steven Palte |
|---|---|
| Gender | Male |
| Speciality | Physician Assistant |
| Experience | 14 Years |
| Location | 801 Medical Dr, Lima, Ohio |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1437442373 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363AS0400X | Physician Assistant - Surgical | 50.003331 (Ohio) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Mercy Health - Defiance Hospital | Defiance, OH | Hospital |
| Mercy Health-st Rita's Medical Center | Lima, OH | Hospital |
| Institute For Orthopaedic Surgery | Lima, OH | Hospital |
| Lima Memorial Health System | Lima, OH | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Orthopaedic Institute Of Ohio Inc | 2860479078 | 69 |
| Mercy Medical Partners Northern Region Specialty Care Llc | 9739585480 | 79 |
News Archive
An $18 million research program headed by Washington University School of Medicine in St. Louis will research therapies and diagnostic tools for heart and lung diseases that use nanotechnology.
Cardinal Health today announced an agreement to acquire privately held AccessClosure Inc., a leading manufacturer and distributor of extravascular closure devices in the United States, for $320 million. Subject to customary closing conditions and regulatory clearances, the all-cash transaction is expected to close by early June 2014.
Children with autism, people with spine and brain injuries and the long-term disabled in job programs are among the 30,000 people who would lose state help under a $5.1 billion spending plan approved by a House committee Thursday.
Cardiovascular Systems, Inc., announced today that its CALCIUM 360° Study, the first-of-its kind prospective, randomized feasibility study, demonstrated the safety and effectiveness of plaque modification with the Diamondback 360 PAD System versus the standard of care treatment (balloon angioplasty) in below-the-knee arteries.
Mycovia Pharmaceuticals, making its official debut as a company developing therapies in women's health and dermatology, today announced the initiation of two Phase 3 clinical trials called VIOLET to evaluate the safety and efficacy of its lead candidate, VT-1161, in patients with recurrent vulvovaginal candidiasis
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Steven Palte, PA-C 801 Medical Dr, Suite A, Lima, OH 45804-4031 Ph: (419) 222-6622 | Steven Palte, PA-C 801 Medical Dr, Suite A, Lima, OH 45804-4031 Ph: (419) 222-6622 |
News Archive
An $18 million research program headed by Washington University School of Medicine in St. Louis will research therapies and diagnostic tools for heart and lung diseases that use nanotechnology.
Cardinal Health today announced an agreement to acquire privately held AccessClosure Inc., a leading manufacturer and distributor of extravascular closure devices in the United States, for $320 million. Subject to customary closing conditions and regulatory clearances, the all-cash transaction is expected to close by early June 2014.
Children with autism, people with spine and brain injuries and the long-term disabled in job programs are among the 30,000 people who would lose state help under a $5.1 billion spending plan approved by a House committee Thursday.
Cardiovascular Systems, Inc., announced today that its CALCIUM 360° Study, the first-of-its kind prospective, randomized feasibility study, demonstrated the safety and effectiveness of plaque modification with the Diamondback 360 PAD System versus the standard of care treatment (balloon angioplasty) in below-the-knee arteries.
Mycovia Pharmaceuticals, making its official debut as a company developing therapies in women's health and dermatology, today announced the initiation of two Phase 3 clinical trials called VIOLET to evaluate the safety and efficacy of its lead candidate, VT-1161, in patients with recurrent vulvovaginal candidiasis
› Verified 7 days ago
Alicia Thornton, PA-C Physician Assistant Medicare: Medicare Enrolled Practice Location: 1001 Bellefontaine Ave, Lima, OH 45804 Phone: 419-228-3335 | |
Mrs. Natalie B Coon, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 1003 Bellefontaine Ave, Suite 125, Lima, OH 45804 Phone: 419-998-8207 Fax: 419-998-8216 | |
Cameron Everett Pappa, PA Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 830 W High St Ste 360, Lima, OH 45801 Phone: 419-227-7117 Fax: 419-227-2848 | |
Mrs. Sierra N Bielcassarino, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 1003 Bellefontaine Ave Ste 150, Lima, OH 45804 Phone: 419-998-8295 Fax: 419-226-8323 | |
Timothy Ohlemacher, Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 770 W High St Ste 160, Lima, OH 45801 Phone: 419-996-5224 Fax: 419-996-5276 | |
Lindsey Alexandra Schroeder, Physician Assistant Medicare: Not Enrolled in Medicare Practice Location: 1003 Bellefontaine Ave, Lima, OH 45804 Phone: 419-228-3335 | |
Tanner Stippich, Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 801 Medical Dr Ste A, Lima, OH 45804 Phone: 419-222-6622 Fax: 419-224-0015 |